{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:43:51Z","timestamp":1780317831785,"version":"3.54.1"},"reference-count":68,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005117","name":"Birjand University of Medical Sciences","doi-asserted-by":"publisher","award":["IR.BUMS.REC.1402.410"],"award-info":[{"award-number":["IR.BUMS.REC.1402.410"]}],"id":[{"id":"10.13039\/501100005117","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Sjogren\u2019s syndrome (SS) is considered as a chronic, autoimmune disorder, that can present with various manifestations both intra and extra-glandular. Cognitive dysfunction is pivotal in recognizing neurological complications in SS.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>A study involving 44 SS cases and 37 controls was conducted to evaluate cognitive dysfunction further. Participants underwent multiple cognitive tests and blood tests for evaluation. Also, the \u03b2-site amyloid precursor protein cleaving enzyme 1 (BACE1), Interleukin 6 (IL-6), total antioxidant capacity (TAC), nitric oxide (NO), and malondialdehyde (MDA) serum levels were measured. Multiple analyses were done by PRISM 10 and SPSS 22.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>The MoCA and SDLT scores were lower in Sjogren patients (P\u2009&lt;\u20090.001). Serum BACE1, IL-6, NO, TAC, and MDA did not statistically vary in the SS patients. The only variables varied by medication therapy with methotrexate (MTX), hydroxychloroquine (HCQ), and prednisone were WBC count (P\u2009=\u20090.03) and triglyceride levels (in MTX and HCQ, P\u2009=\u20090.04), with no effect on neurocognitive factors. IL-6 was strongly correlated with the duration of symptoms (r\u2009=\u20090.99, P-value\u2009&lt;\u20090.001). BACE1 had a positive correlation with IL-6 level (r\u2009=\u20090.4, P-value\u2009=\u20090.027).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>SS patients demonstrated significantly lower performance in neurocognitive tests, while BACE1 and inflammatory markers were not altered. This indicates that cognitive decline in SS is present but the mechanism still requires further evaluation. MTX, HCQ, and Prednisone use did not alter neurocognitive factors. Important correlations were found between hematological and cognitive tests in this study which provides new insights in the field of SS.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0328311","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T17:26:03Z","timestamp":1754069163000},"page":"e0328311","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cognitive impairment in Sjogren\u2019s syndrome: Interplay between BACE1 activity, inflammatory blood biomarkers and neurocognitive testing"],"prefix":"10.1371","volume":"20","author":[{"given":"Alireza","family":"Kooshki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyhane","family":"Farmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Kabiri-Rad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossien","family":"Nezami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhosein","family":"Zardast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2317-6159","authenticated-orcid":true,"given":"Zeinab","family":"Saremi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"issue":"1","key":"pone.0328311.ref001","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10238-021-00728-6","article-title":"Sj\u00f6gren\u2019s syndrome: a systemic autoimmune disease","volume":"22","author":"S Negrini","year":"2022","journal-title":"Clin Exp Med"},{"issue":"7","key":"pone.0328311.ref002","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/lary.29233","article-title":"Sialendoscopy and sjogren\u2019s disease: a systematic review","volume":"131","author":"KK Coca","year":"2021","journal-title":"Laryngoscope"},{"issue":"4","key":"pone.0328311.ref003","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40674-017-0076-9","article-title":"Neurological complications of sj\u00f6gren\u2019s syndrome: diagnosis and management","volume":"3","author":"SS McCoy","year":"2017","journal-title":"Curr Treatm Opt Rheumatol"},{"issue":"2","key":"pone.0328311.ref004","doi-asserted-by":"crossref","first-page":"99","DOI":"10.5114\/reum.2018.75521","article-title":"Neurological manifestations of primary Sj\u00f6gren\u2019s syndrome","volume":"56","author":"J Perzy\u0144ska-Mazan","year":"2018","journal-title":"Reumatologia"},{"issue":"4","key":"pone.0328311.ref005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3390\/brainsci9040085","article-title":"Cognitive function in primary sj\u00f6gren\u2019s syndrome: a systematic review","volume":"9","author":"C Manzo","year":"2019","journal-title":"Brain Sci"},{"issue":"1","key":"pone.0328311.ref006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084605","article-title":"Neurological involvement in primary Sj\u00f6gren syndrome: a focus on central nervous system","volume":"9","author":"M Morreale","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"pone.0328311.ref007","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2015-000179","article-title":"Epidemiology of neurological manifestations in Sj\u00f6gren\u2019s syndrome: data from the French ASSESS Cohort","volume":"2","author":"G Carvajal Alegria","year":"2016","journal-title":"RMD Open"},{"key":"pone.0328311.ref008","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jns.2012.07.060","article-title":"Prevalence of Sj\u00f6gren\u2019s syndrome with dementia in a memory clinic","volume":"322","author":"K Yoshikawa","year":"2012","journal-title":"J Neurol Sci"},{"issue":"4","key":"pone.0328311.ref009","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s12011-024-04326-x","article-title":"Alzheimer\u2019s disease and circulatory imbalance of toxic heavy metals: a systematic review and meta-analysis of clinical studies","volume":"203","author":"A Kooshki","year":"2025","journal-title":"Biol Trace Elem Res"},{"issue":"36","key":"pone.0328311.ref010","article-title":"A possible mechanism for the enhanced toxicity of beta-amyloid protofibrils in Alzheimer\u2019s disease","volume":"120","author":"Z-L Chen","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"pone.0328311.ref011","doi-asserted-by":"crossref","first-page":"369","DOI":"10.4103\/apjtb.apjtb_192_24","article-title":"BACE1 inhibitors: A promising therapeutic approach for the management of Alzheimer\u2019s disease","volume":"14","author":"R Arya","year":"2024","journal-title":"Asian Pac J Trop Biomed"},{"issue":"2","key":"pone.0328311.ref012","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.molmed.2022.11.008","article-title":"Unmasking BACE1 in aging and age-related diseases","volume":"29","author":"H Bao","year":"2023","journal-title":"Trends Mol Med"},{"issue":"5","key":"pone.0328311.ref013","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3928\/0098-9134-19990501-08","article-title":"The Mini-Mental State Examination (MMSE)","volume":"25","author":"L Kurlowicz","year":"1999","journal-title":"J Gerontol Nurs"},{"issue":"3","key":"pone.0328311.ref014","first-page":"190","article-title":"Validation of a Mini-Mental State Examination (MMSE) for the Persian population: a pilot study","volume":"17","author":"NN Ansari","year":"2010","journal-title":"Appl Neuropsychol"},{"issue":"9","key":"pone.0328311.ref015","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/occmed\/kqv078","article-title":"The Montreal Cognitive Assessment (MoCA)","volume":"65","author":"J Hobson","year":"2015","journal-title":"Occup Med (Lond)"},{"issue":"1","key":"pone.0328311.ref016","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000514673","article-title":"Psychometric properties of the persian montreal cognitive assessment in mild cognitive impairment and alzheimer disease","volume":"11","author":"V Rashedi","year":"2021","journal-title":"Dement Geriatr Cogn Dis Extra"},{"issue":"8","key":"pone.0328311.ref017","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1212\/WNL.45.8.1637-a","article-title":"Contributions to neuropsychological assessment","volume":"45","author":"N Adams","year":"1995","journal-title":"Neurology"},{"issue":"1","key":"pone.0328311.ref018","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11325-010-0478-5","article-title":"Reliability and validity of the Persian version of the Pittsburgh Sleep Quality Index (PSQI-P)","volume":"16","author":"J Farrahi Moghaddam","year":"2012","journal-title":"Sleep Breath"},{"issue":"2","key":"pone.0328311.ref019","first-page":"119","article-title":"Validation of the persian version of the pittsburgh sleep quality index in elderly population","volume":"13","author":"A Chehri","year":"2020","journal-title":"Sleep Sci"},{"issue":"8","key":"pone.0328311.ref020","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1665","article-title":"Neuro-Sj\u00f6gren: uncommon or underestimated problem?","volume":"10","author":"M Jask\u00f3lska","year":"2020","journal-title":"Brain Behav"},{"issue":"10","key":"pone.0328311.ref021","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1007\/s00204-023-03562-9","article-title":"Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging","volume":"97","author":"K Jomova","year":"2023","journal-title":"Arch Toxicol"},{"issue":"23","key":"pone.0328311.ref022","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.3390\/cells12232726","article-title":"The role of cortisol in chronic stress, neurodegenerative diseases, and psychological disorders","volume":"12","author":"E Knezevic","year":"2023","journal-title":"Cells"},{"issue":"6393","key":"pone.0328311.ref023","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/359322a0","article-title":"Amyloid beta-peptide is produced by cultured cells during normal metabolism","volume":"359","author":"C Haass","year":"1992","journal-title":"Nature"},{"issue":"6409","key":"pone.0328311.ref024","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/361260a0","article-title":"Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide","volume":"361","author":"P Seubert","year":"1993","journal-title":"Nature"},{"issue":"41","key":"pone.0328311.ref025","doi-asserted-by":"crossref","first-page":"12787","DOI":"10.1523\/JNEUROSCI.3657-09.2009","article-title":"The beta-secretase enzyme BACE in health and Alzheimer\u2019s disease: regulation, cell biology, function, and therapeutic potential","volume":"29","author":"R Vassar","year":"2009","journal-title":"J Neurosci"},{"issue":"1","key":"pone.0328311.ref026","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3233\/JAD-2010-1367","article-title":"BACE1 activity in cerebrospinal fluid and its relation to markers of AD pathology","volume":"20","author":"SD Mulder","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"pone.0328311.ref027","article-title":"P3\u2010083: Beta\u2010secretase levels changed in mild cognitive impairment patients\u2019 brains and cerebral spinal fluid","volume":"4","author":"R Li","year":"2008","journal-title":"Alzheimer\u2019s Dement"},{"issue":"2","key":"pone.0328311.ref028","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3233\/JAD-2011-091153","article-title":"Increased CSF-BACE1 activity associated with decreased hippocampus volume in Alzheimer\u2019s disease","volume":"25","author":"M Ewers","year":"2011","journal-title":"J Alzheimers Dis"},{"issue":"8","key":"pone.0328311.ref029","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1001\/archneur.65.8.1102","article-title":"Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease","volume":"65","author":"H Zetterberg","year":"2008","journal-title":"Arch Neurol"},{"issue":"10","key":"pone.0328311.ref030","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jalz.2019.07.001","article-title":"Brain A\u03b2 load association and sexual dimorphism of plasma BACE1 concentrations in cognitively normal individuals at risk for AD","volume":"15","author":"A Vergallo","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"3","key":"pone.0328311.ref031","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/jnc.15513","article-title":"Serum beta-secretase 1 (BACE1) activity increases in patients with mild cognitive impairment","volume":"159","author":"G Zuliani","year":"2021","journal-title":"J Neurochem"},{"issue":"4","key":"pone.0328311.ref032","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/alz.12228","article-title":"Plasma \u03b2-secretase1 concentrations correlate with basal forebrain atrophy and neurodegeneration in cognitively healthy individuals at risk for AD","volume":"17","author":"A Vergallo","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"2","key":"pone.0328311.ref033","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3233\/JAD-142778","article-title":"Soluble BACE-1 activity and sA\u03b2PP\u03b2 concentrations in alzheimer\u2019s disease and age-matched healthy control cerebrospinal fluid from the alzheimer\u2019s disease neuroimaging initiative-1 baseline cohort","volume":"46","author":"MJ Savage","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"12","key":"pone.0328311.ref034","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.clinbiochem.2008.04.022","article-title":"Decrease in age-adjusted cerebrospinal fluid \u03b2-secretase activity in Alzheimer\u2019s subjects","volume":"41","author":"G Wu","year":"2008","journal-title":"Clinical Biochemistry"},{"issue":"5","key":"pone.0328311.ref035","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.biopsych.2017.02.007","article-title":"Increased plasma beta-secretase 1 may predict conversion to alzheimer\u2019s disease dementia in individuals with mild cognitive impairment","volume":"83","author":"Y Shen","year":"2018","journal-title":"Biol Psychiatry"},{"issue":"1","key":"pone.0328311.ref036","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3233\/JAD-215542","article-title":"Increased serum beta-secretase 1 activity is an early marker of alzheimer\u2019s disease","volume":"87","author":"R Nicsanu","year":"2022","journal-title":"JAD"},{"key":"pone.0328311.ref037","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000488481","article-title":"Cerebrospinal fluid BACE1 activity and sA\u03b2PP\u03b2 as biomarker candidates of alzheimer\u2019s disease","volume":"45","author":"P Alexopoulos","year":"2018","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"3","key":"pone.0328311.ref038","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jamaneurol.2020.4857","article-title":"Findings of efficacy, safety, and biomarker outcomes of atabecestat in preclinical alzheimer disease: a truncated randomized phase 2b\/3 clinical trial","volume":"78","author":"R Sperling","year":"2021","journal-title":"JAMA Neurol"},{"issue":"3","key":"pone.0328311.ref039","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12781","article-title":"Neuropathology of a patient with Alzheimer disease treated with low doses of verubecestat","volume":"48","author":"M Querol-Vilaseca","year":"2022","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"pone.0328311.ref040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/ageing\/19.2.91","article-title":"The association of education and socioeconomic status with the Mini Mental State Examination and the clinical diagnosis of dementia in elderly people","volume":"19","author":"C Brayne","year":"1990","journal-title":"Age Ageing"},{"issue":"10","key":"pone.0328311.ref041","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1212\/WNL.38.10.1565","article-title":"Age-specific norms for the Mini-Mental State Exam","volume":"38","author":"ML Bleecker","year":"1988","journal-title":"Neurology"},{"issue":"4","key":"pone.0328311.ref042","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"ZS Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"pone.0328311.ref043","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/gps.4880","article-title":"Screening an elderly hearing impaired population for mild cognitive impairment using Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA)","volume":"33","author":"MYL Lim","year":"2018","journal-title":"Int J Geriatr Psychiatry"},{"key":"pone.0328311.ref044","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0736-5748(00)00012-5","article-title":"Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology","volume":"18","author":"G Mehlhorn","year":"2000","journal-title":"Int J Dev Neurosci"},{"issue":"2","key":"pone.0328311.ref045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/bih.76.2.97.106","article-title":"Application of triple immunohistochemistry to characterize amyloid plaque-associated inflammation in brains with Alzheimer\u2019s disease","volume":"76","author":"MR D\u2019Andrea","year":"2001","journal-title":"Biotech Histochem"},{"issue":"4","key":"pone.0328311.ref046","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/psyg.12403","article-title":"Peripheral inflammatory biomarkers in Alzheimer\u2019s disease and mild cognitive impairment: a systematic review and meta-analysis","volume":"19","author":"C Su","year":"2019","journal-title":"Psychogeriatrics"},{"issue":"9","key":"pone.0328311.ref047","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1096\/fj.03-1378fje","article-title":"Gene structure and organization of the human beta-secretase (BACE) promoter","volume":"18","author":"K Sambamurti","year":"2004","journal-title":"FASEB J"},{"key":"pone.0328311.ref048","article-title":"P3\u2010063: A novel BACE1\u2010regulating protein with therapeutic potential","volume":"8","author":"RMD Holsinger","year":"2012","journal-title":"Alzheimer\u2019s Dement"},{"issue":"9","key":"pone.0328311.ref049","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.3390\/biomedicines11092394","article-title":"Concordant and discordant cerebrospinal fluid and plasma cytokine and chemokine responses in mild cognitive impairment and early-stage alzheimer\u2019s disease","volume":"11","author":"SM de la Monte","year":"2023","journal-title":"Biomedicines"},{"issue":"5","key":"pone.0328311.ref050","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/jnnp-2018-319148","article-title":"Inflammatory markers in Alzheimer\u2019s disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies","volume":"90","author":"X-N Shen","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"pone.0328311.ref051","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-immunol-101220-023458","article-title":"IL-6 revisited: from rheumatoid arthritis to CAR T cell therapy and COVID-19","volume":"40","author":"T Kishimoto","year":"2022","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"pone.0328311.ref052","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/1759720X10378372","article-title":"The role of interleukin 6 in the pathophysiology of rheumatoid arthritis","volume":"2","author":"S Srirangan","year":"2010","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"4","key":"pone.0328311.ref053","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3899\/jrheum.120725","article-title":"Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis","volume":"40","author":"A De Lauretis","year":"2013","journal-title":"J Rheumatol"},{"issue":"7","key":"pone.0328311.ref054","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/annrheumdis-2011-200955","article-title":"Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis","volume":"71","author":"K Khan","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"pone.0328311.ref055","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20175738","article-title":"Cytokine profile in childhood-onset systemic lupus erythematosus: a cross-sectional and longitudinal study","volume":"50","author":"A Cavalcanti","year":"2017","journal-title":"Braz J Med Biol Res"},{"issue":"1","key":"pone.0328311.ref056","doi-asserted-by":"crossref","DOI":"10.4081\/gc.2020.8785","article-title":"Brief report on cognitive function and corticosteroid therapy in elderly","volume":"6","author":"A Castagna","year":"2020","journal-title":"Geriatr Care"},{"issue":"11","key":"pone.0328311.ref057","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/acr.24369","article-title":"Systematic literature review of residual symptoms and an unmet need in patients with rheumatoid arthritis","volume":"73","author":"K Michaud","year":"2021","journal-title":"Arthritis Care Res"},{"issue":"3","key":"pone.0328311.ref058","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/medicines5030082","article-title":"Behavioral, psychiatric, and cognitive adverse events in older persons treated with glucocorticoids","volume":"5","author":"C Manzo","year":"2018","journal-title":"Medicines"},{"key":"pone.0328311.ref059","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0022-4731(81)90270-3","article-title":"Pathophysiology of the adverse effects of glucoactive corticosteroids on calcium metabolism in man","volume":"15","author":"A Caniggia","year":"1981","journal-title":"J Steroid Biochem"},{"issue":"12","key":"pone.0328311.ref060","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.586","article-title":"Cognition, depression, fatigue, and quality of life in primary Sj\u00f6gren\u2019s syndrome: correlations","volume":"6","author":"B Ko\u00e7er","year":"2016","journal-title":"Brain Behav"},{"issue":"6","key":"pone.0328311.ref061","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.70006","article-title":"Investigating the correlation between cognitive function and fasting blood sugar, fasting insulin level and insulin sensitivity in patients with multiple sclerosis","volume":"7","author":"N Rezaeimanesh","year":"2024","journal-title":"Endocrinol Diabetes Metab"},{"issue":"4","key":"pone.0328311.ref062","first-page":"303","article-title":"A study of serum magnesium, calcium and phosphorus level, and cognition in the elderly population of South India","volume":"52","author":"MP Basheer","year":"2016","journal-title":"Alex J Med"},{"issue":"3","key":"pone.0328311.ref063","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/s41380-022-01912-0","article-title":"Hydroxychloroquine lowers Alzheimer\u2019s disease and related dementias risk and rescues molecular phenotypes related to Alzheimer\u2019s disease","volume":"28","author":"VR Varma","year":"2023","journal-title":"Mol Psychiatry"},{"issue":"9280","key":"pone.0328311.ref064","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0140-6736(01)05623-9","article-title":"Effect of hydroxychloroquine on progression of dementia in early Alzheimer\u2019s disease: an 18-month randomised, double-blind, placebo-controlled study","volume":"358","author":"WA Van Gool","year":"2001","journal-title":"Lancet"},{"issue":"1","key":"pone.0328311.ref065","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13256-024-04390-w","article-title":"Azathioprine and hydroxychloroquine overdose in Sj\u00f6gren\u2019s syndrome patient with hypocalcemia: a case report","volume":"18","author":"A Kooshki","year":"2024","journal-title":"J Med Case Rep"},{"issue":"2","key":"pone.0328311.ref066","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.crohns.2013.09.014","article-title":"Azathioprine-induced neuro-psychiatric disorders","volume":"8","author":"G Bouguen","year":"2014","journal-title":"J Crohn\u2019s Colitis"},{"issue":"3","key":"pone.0328311.ref067","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s11065-019-09405-8","article-title":"Corticosteroids and cognition: a meta-analysis","volume":"29","author":"CE Prado","year":"2019","journal-title":"Neuropsychol Rev"},{"issue":"7","key":"pone.0328311.ref068","doi-asserted-by":"crossref","first-page":"102845","DOI":"10.1016\/j.autrev.2021.102845","article-title":"Hygiene hypothesis and autoimmune diseases: A narrative review of clinical evidences and mechanisms","volume":"20","author":"G Murdaca","year":"2021","journal-title":"Autoimmun Rev"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0328311","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T17:26:12Z","timestamp":1754069172000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0328311"}},"subtitle":[],"editor":[{"given":"Stephen D.","family":"Ginsberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":68,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0328311","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]}}}